Showing results (21-30 of 50) with videos related to
Sort By:
Pageof 5
Environmental Health Perspectives|May 22, 2012
The organochlorine o,p'-DDT plays a role in coactivator-mediated MAPK crosstalk in MCF-7 breast cancer cellsMelyssa R Bratton, Daniel E Frigo, H Chris Segar, et al.American Journal of Cancer Research|August 4, 2012
Pharmacology and anti-tumor activity of RWJ67657, a novel inhibitor of p38 mitogen activated protein kinaseJames W Antoon, Melyssa R Bratton, Lori M Guillot, et al.Journal of Agricultural and Food Chemistry|December 8, 2010
Estrogenic and antiestrogenic activities of phytoalexins from red kidney bean (Phaseolus vulgaris L.)Stephen M Boué, Matthew E Burow, Thomas E Wiese, et al.International Journal of Oncology|February 11, 2005
PKC-mediated survival signaling in breast carcinoma cells: a role for MEK1-AP1 signalingChristopher B Weldon, Amy McKee, Bridgette M Collins-Burow, et al.Reproductive Toxicology (Elmsford, N.Y.)|July 14, 2007
In vitro molecular mechanisms of bisphenol A actionYelena B Wetherill, Benson T Akingbemi, Jun Kanno, et al.The Journal of Nutrition|July 5, 2002
Flavonoid phytochemicals regulate activator protein-1 signal transduction pathways in endometrial and kidney stable cell linesDaniel E Frigo, Bich N Duong, Lilia I Melnik, et al.Endocrinology|January 31, 2009
Human uterine smooth muscle and leiomyoma cells differ in their rapid 17beta-estradiol signaling: implications for proliferationErica N Nierth-Simpson, Melvenia M Martin, Tung-Chin Chiang, et al.Journal of Health Care for the Poor and Underserved|February 12, 2013
Phytoalexins, miRNAs and breast cancer: a review of phytochemical-mediated miRNA regulation in breast cancerSyreeta L Tilghman, Lyndsay V Rhodes, Melyssa R Bratton, et al.Journal of Agricultural and Food Chemistry|April 3, 2003
Evaluation of the estrogenic effects of legume extracts containing phytoestrogensStephen M Boué, Thomas E Wiese, Suzanne Nehls, et al.Journal of Health Care for the Poor and Underserved|February 12, 2013
In vitro and in vivo evaluation of novel anticancer agents in triple negative breast cancer modelsKiTani Parker Johnson, Letitia A Yearby, Diana Stoute, et al.Pageof 5